Biotech

All Articles

Sanofi's tolebrutinib falls short 2 of 3 late-stage MS trials

.Sanofi is still set on taking its several sclerosis (MS) med tolebrutinib to the FDA, executives ha...

Galapagos' stockpile as fund presents intent to mold its own advancement

.Galapagos is actually coming under added pressure coming from investors. Having actually created a ...

Cell- centered Sana gathers very first CSO-- Chutes &amp Ladders

.Accept to recently's Chutes &amp Ladders, our roundup of considerable management hirings, firings a...

Allist pays Jacobio $21M, landing task in Mandarin KRAS ethnicity

.Shanghai Allist Pharmaceuticals has actually gotten on its own a starring character in China's KRAS...

ReNeuron leaving behind AIM substitution after missing fundraising target

.ReNeuron has actually signed up with the lengthy listing of biotechs to leave London's goal stock m...

MBX declare IPO to take challenger to Ascendis into phase 3

.MBX Biosciences has actually contributed to the latest spurt of IPO filings. The biotech, which fil...

FDA broadens probe in to Lykos' MDMA tests: WSJ

.For Lykos Therapies and the business's potential MDMA-assisted treatment for post-traumatic stress ...

Gene editor Tome laying off 131 laborers

.Just days after gene publisher Volume Biosciences announced hidden working slices, a more clear pic...

Repare lays off 25% of personnel as biotech stops preclinical R&ampD

.Repare Rehab is laying off an one-fourth of its own workforce as the oncology biotech downsize its ...

J &amp J declare FDA permission of $6.5 B autoimmune medicine

.Johnson &amp Johnson has taken yet another step towards noticing a yield on its $6.5 billion nipoca...